We've found
2,621
archived clinical trials in
Urology
We've found
2,621
archived clinical trials in
Urology
Autologous Muscle Derived Cells for Female Urinary Sphincter Repair
Updated: 12/31/1969
A Double-blind, Randomized, Controlled Trial Comparing the Safety and Efficacy of AMDC-USR With Placebo in Female Subjects With Stress Urinary Incontinence
Status: Enrolling
Updated: 12/31/1969
Autologous Muscle Derived Cells for Female Urinary Sphincter Repair
Updated: 12/31/1969
A Double-blind, Randomized, Controlled Trial Comparing the Safety and Efficacy of AMDC-USR With Placebo in Female Subjects With Stress Urinary Incontinence
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Autologous Muscle Derived Cells for Female Urinary Sphincter Repair
Updated: 12/31/1969
A Double-blind, Randomized, Controlled Trial Comparing the Safety and Efficacy of AMDC-USR With Placebo in Female Subjects With Stress Urinary Incontinence
Status: Enrolling
Updated: 12/31/1969
Autologous Muscle Derived Cells for Female Urinary Sphincter Repair
Updated: 12/31/1969
A Double-blind, Randomized, Controlled Trial Comparing the Safety and Efficacy of AMDC-USR With Placebo in Female Subjects With Stress Urinary Incontinence
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Autologous Muscle Derived Cells for Female Urinary Sphincter Repair
Updated: 12/31/1969
A Double-blind, Randomized, Controlled Trial Comparing the Safety and Efficacy of AMDC-USR With Placebo in Female Subjects With Stress Urinary Incontinence
Status: Enrolling
Updated: 12/31/1969
Autologous Muscle Derived Cells for Female Urinary Sphincter Repair
Updated: 12/31/1969
A Double-blind, Randomized, Controlled Trial Comparing the Safety and Efficacy of AMDC-USR With Placebo in Female Subjects With Stress Urinary Incontinence
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Autologous Muscle Derived Cells for Female Urinary Sphincter Repair
Updated: 12/31/1969
A Double-blind, Randomized, Controlled Trial Comparing the Safety and Efficacy of AMDC-USR With Placebo in Female Subjects With Stress Urinary Incontinence
Status: Enrolling
Updated: 12/31/1969
Autologous Muscle Derived Cells for Female Urinary Sphincter Repair
Updated: 12/31/1969
A Double-blind, Randomized, Controlled Trial Comparing the Safety and Efficacy of AMDC-USR With Placebo in Female Subjects With Stress Urinary Incontinence
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Autologous Muscle Derived Cells for Female Urinary Sphincter Repair
Updated: 12/31/1969
A Double-blind, Randomized, Controlled Trial Comparing the Safety and Efficacy of AMDC-USR With Placebo in Female Subjects With Stress Urinary Incontinence
Status: Enrolling
Updated: 12/31/1969
Autologous Muscle Derived Cells for Female Urinary Sphincter Repair
Updated: 12/31/1969
A Double-blind, Randomized, Controlled Trial Comparing the Safety and Efficacy of AMDC-USR With Placebo in Female Subjects With Stress Urinary Incontinence
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Safety and Initial Efficacy Study of the Vortx Rx for Treatment of Benign Prostatic Hyperplasia (US)
Updated: 12/31/1969
Safety and Initial Efficacy Study of the Vortx Rx for Treatment of Benign Prostatic Hyperplasia (US)
Status: Enrolling
Updated: 12/31/1969
Safety and Initial Efficacy Study of the Vortx Rx for Treatment of Benign Prostatic Hyperplasia (US)
Updated: 12/31/1969
Safety and Initial Efficacy Study of the Vortx Rx for Treatment of Benign Prostatic Hyperplasia (US)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Safety and Initial Efficacy Study of the Vortx Rx for Treatment of Benign Prostatic Hyperplasia (US)
Updated: 12/31/1969
Safety and Initial Efficacy Study of the Vortx Rx for Treatment of Benign Prostatic Hyperplasia (US)
Status: Enrolling
Updated: 12/31/1969
Safety and Initial Efficacy Study of the Vortx Rx for Treatment of Benign Prostatic Hyperplasia (US)
Updated: 12/31/1969
Safety and Initial Efficacy Study of the Vortx Rx for Treatment of Benign Prostatic Hyperplasia (US)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Post Market Study Of Single Incision Sling Versus Transobturator Sling for Stress Urinary Incontinence
Updated: 12/31/1969
A Prospective, Non-Randomized, Parallel Cohort, Multi-center Study of the Solyx™ Single Incision Sling System vs. the Obtryx™ II Sling System for the Treatment of Women With Stress Urinary Incontinence
Status: Enrolling
Updated: 12/31/1969
Post Market Study Of Single Incision Sling Versus Transobturator Sling for Stress Urinary Incontinence
Updated: 12/31/1969
A Prospective, Non-Randomized, Parallel Cohort, Multi-center Study of the Solyx™ Single Incision Sling System vs. the Obtryx™ II Sling System for the Treatment of Women With Stress Urinary Incontinence
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Post Market Study Of Single Incision Sling Versus Transobturator Sling for Stress Urinary Incontinence
Updated: 12/31/1969
A Prospective, Non-Randomized, Parallel Cohort, Multi-center Study of the Solyx™ Single Incision Sling System vs. the Obtryx™ II Sling System for the Treatment of Women With Stress Urinary Incontinence
Status: Enrolling
Updated: 12/31/1969
Post Market Study Of Single Incision Sling Versus Transobturator Sling for Stress Urinary Incontinence
Updated: 12/31/1969
A Prospective, Non-Randomized, Parallel Cohort, Multi-center Study of the Solyx™ Single Incision Sling System vs. the Obtryx™ II Sling System for the Treatment of Women With Stress Urinary Incontinence
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Post Market Study Of Single Incision Sling Versus Transobturator Sling for Stress Urinary Incontinence
Updated: 12/31/1969
A Prospective, Non-Randomized, Parallel Cohort, Multi-center Study of the Solyx™ Single Incision Sling System vs. the Obtryx™ II Sling System for the Treatment of Women With Stress Urinary Incontinence
Status: Enrolling
Updated: 12/31/1969
Post Market Study Of Single Incision Sling Versus Transobturator Sling for Stress Urinary Incontinence
Updated: 12/31/1969
A Prospective, Non-Randomized, Parallel Cohort, Multi-center Study of the Solyx™ Single Incision Sling System vs. the Obtryx™ II Sling System for the Treatment of Women With Stress Urinary Incontinence
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Post Market Study Of Single Incision Sling Versus Transobturator Sling for Stress Urinary Incontinence
Updated: 12/31/1969
A Prospective, Non-Randomized, Parallel Cohort, Multi-center Study of the Solyx™ Single Incision Sling System vs. the Obtryx™ II Sling System for the Treatment of Women With Stress Urinary Incontinence
Status: Enrolling
Updated: 12/31/1969
Post Market Study Of Single Incision Sling Versus Transobturator Sling for Stress Urinary Incontinence
Updated: 12/31/1969
A Prospective, Non-Randomized, Parallel Cohort, Multi-center Study of the Solyx™ Single Incision Sling System vs. the Obtryx™ II Sling System for the Treatment of Women With Stress Urinary Incontinence
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Post Market Study Of Single Incision Sling Versus Transobturator Sling for Stress Urinary Incontinence
Updated: 12/31/1969
A Prospective, Non-Randomized, Parallel Cohort, Multi-center Study of the Solyx™ Single Incision Sling System vs. the Obtryx™ II Sling System for the Treatment of Women With Stress Urinary Incontinence
Status: Enrolling
Updated: 12/31/1969
Post Market Study Of Single Incision Sling Versus Transobturator Sling for Stress Urinary Incontinence
Updated: 12/31/1969
A Prospective, Non-Randomized, Parallel Cohort, Multi-center Study of the Solyx™ Single Incision Sling System vs. the Obtryx™ II Sling System for the Treatment of Women With Stress Urinary Incontinence
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Post Market Study Of Single Incision Sling Versus Transobturator Sling for Stress Urinary Incontinence
Updated: 12/31/1969
A Prospective, Non-Randomized, Parallel Cohort, Multi-center Study of the Solyx™ Single Incision Sling System vs. the Obtryx™ II Sling System for the Treatment of Women With Stress Urinary Incontinence
Status: Enrolling
Updated: 12/31/1969
Post Market Study Of Single Incision Sling Versus Transobturator Sling for Stress Urinary Incontinence
Updated: 12/31/1969
A Prospective, Non-Randomized, Parallel Cohort, Multi-center Study of the Solyx™ Single Incision Sling System vs. the Obtryx™ II Sling System for the Treatment of Women With Stress Urinary Incontinence
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Post Market Study Of Single Incision Sling Versus Transobturator Sling for Stress Urinary Incontinence
Updated: 12/31/1969
A Prospective, Non-Randomized, Parallel Cohort, Multi-center Study of the Solyx™ Single Incision Sling System vs. the Obtryx™ II Sling System for the Treatment of Women With Stress Urinary Incontinence
Status: Enrolling
Updated: 12/31/1969
Post Market Study Of Single Incision Sling Versus Transobturator Sling for Stress Urinary Incontinence
Updated: 12/31/1969
A Prospective, Non-Randomized, Parallel Cohort, Multi-center Study of the Solyx™ Single Incision Sling System vs. the Obtryx™ II Sling System for the Treatment of Women With Stress Urinary Incontinence
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Post Market Study Of Single Incision Sling Versus Transobturator Sling for Stress Urinary Incontinence
Updated: 12/31/1969
A Prospective, Non-Randomized, Parallel Cohort, Multi-center Study of the Solyx™ Single Incision Sling System vs. the Obtryx™ II Sling System for the Treatment of Women With Stress Urinary Incontinence
Status: Enrolling
Updated: 12/31/1969
Post Market Study Of Single Incision Sling Versus Transobturator Sling for Stress Urinary Incontinence
Updated: 12/31/1969
A Prospective, Non-Randomized, Parallel Cohort, Multi-center Study of the Solyx™ Single Incision Sling System vs. the Obtryx™ II Sling System for the Treatment of Women With Stress Urinary Incontinence
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Post Market Study Of Single Incision Sling Versus Transobturator Sling for Stress Urinary Incontinence
Updated: 12/31/1969
A Prospective, Non-Randomized, Parallel Cohort, Multi-center Study of the Solyx™ Single Incision Sling System vs. the Obtryx™ II Sling System for the Treatment of Women With Stress Urinary Incontinence
Status: Enrolling
Updated: 12/31/1969
Post Market Study Of Single Incision Sling Versus Transobturator Sling for Stress Urinary Incontinence
Updated: 12/31/1969
A Prospective, Non-Randomized, Parallel Cohort, Multi-center Study of the Solyx™ Single Incision Sling System vs. the Obtryx™ II Sling System for the Treatment of Women With Stress Urinary Incontinence
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Post Market Study Of Single Incision Sling Versus Transobturator Sling for Stress Urinary Incontinence
Updated: 12/31/1969
A Prospective, Non-Randomized, Parallel Cohort, Multi-center Study of the Solyx™ Single Incision Sling System vs. the Obtryx™ II Sling System for the Treatment of Women With Stress Urinary Incontinence
Status: Enrolling
Updated: 12/31/1969
Post Market Study Of Single Incision Sling Versus Transobturator Sling for Stress Urinary Incontinence
Updated: 12/31/1969
A Prospective, Non-Randomized, Parallel Cohort, Multi-center Study of the Solyx™ Single Incision Sling System vs. the Obtryx™ II Sling System for the Treatment of Women With Stress Urinary Incontinence
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Post Market Study Of Single Incision Sling Versus Transobturator Sling for Stress Urinary Incontinence
Updated: 12/31/1969
A Prospective, Non-Randomized, Parallel Cohort, Multi-center Study of the Solyx™ Single Incision Sling System vs. the Obtryx™ II Sling System for the Treatment of Women With Stress Urinary Incontinence
Status: Enrolling
Updated: 12/31/1969
Post Market Study Of Single Incision Sling Versus Transobturator Sling for Stress Urinary Incontinence
Updated: 12/31/1969
A Prospective, Non-Randomized, Parallel Cohort, Multi-center Study of the Solyx™ Single Incision Sling System vs. the Obtryx™ II Sling System for the Treatment of Women With Stress Urinary Incontinence
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Post Market Study Of Single Incision Sling Versus Transobturator Sling for Stress Urinary Incontinence
Updated: 12/31/1969
A Prospective, Non-Randomized, Parallel Cohort, Multi-center Study of the Solyx™ Single Incision Sling System vs. the Obtryx™ II Sling System for the Treatment of Women With Stress Urinary Incontinence
Status: Enrolling
Updated: 12/31/1969
Post Market Study Of Single Incision Sling Versus Transobturator Sling for Stress Urinary Incontinence
Updated: 12/31/1969
A Prospective, Non-Randomized, Parallel Cohort, Multi-center Study of the Solyx™ Single Incision Sling System vs. the Obtryx™ II Sling System for the Treatment of Women With Stress Urinary Incontinence
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Post Market Study Of Single Incision Sling Versus Transobturator Sling for Stress Urinary Incontinence
Updated: 12/31/1969
A Prospective, Non-Randomized, Parallel Cohort, Multi-center Study of the Solyx™ Single Incision Sling System vs. the Obtryx™ II Sling System for the Treatment of Women With Stress Urinary Incontinence
Status: Enrolling
Updated: 12/31/1969
Post Market Study Of Single Incision Sling Versus Transobturator Sling for Stress Urinary Incontinence
Updated: 12/31/1969
A Prospective, Non-Randomized, Parallel Cohort, Multi-center Study of the Solyx™ Single Incision Sling System vs. the Obtryx™ II Sling System for the Treatment of Women With Stress Urinary Incontinence
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Post Market Study Of Single Incision Sling Versus Transobturator Sling for Stress Urinary Incontinence
Updated: 12/31/1969
A Prospective, Non-Randomized, Parallel Cohort, Multi-center Study of the Solyx™ Single Incision Sling System vs. the Obtryx™ II Sling System for the Treatment of Women With Stress Urinary Incontinence
Status: Enrolling
Updated: 12/31/1969
Post Market Study Of Single Incision Sling Versus Transobturator Sling for Stress Urinary Incontinence
Updated: 12/31/1969
A Prospective, Non-Randomized, Parallel Cohort, Multi-center Study of the Solyx™ Single Incision Sling System vs. the Obtryx™ II Sling System for the Treatment of Women With Stress Urinary Incontinence
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Post Market Study Of Single Incision Sling Versus Transobturator Sling for Stress Urinary Incontinence
Updated: 12/31/1969
A Prospective, Non-Randomized, Parallel Cohort, Multi-center Study of the Solyx™ Single Incision Sling System vs. the Obtryx™ II Sling System for the Treatment of Women With Stress Urinary Incontinence
Status: Enrolling
Updated: 12/31/1969
Post Market Study Of Single Incision Sling Versus Transobturator Sling for Stress Urinary Incontinence
Updated: 12/31/1969
A Prospective, Non-Randomized, Parallel Cohort, Multi-center Study of the Solyx™ Single Incision Sling System vs. the Obtryx™ II Sling System for the Treatment of Women With Stress Urinary Incontinence
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Post Market Study Of Single Incision Sling Versus Transobturator Sling for Stress Urinary Incontinence
Updated: 12/31/1969
A Prospective, Non-Randomized, Parallel Cohort, Multi-center Study of the Solyx™ Single Incision Sling System vs. the Obtryx™ II Sling System for the Treatment of Women With Stress Urinary Incontinence
Status: Enrolling
Updated: 12/31/1969
Post Market Study Of Single Incision Sling Versus Transobturator Sling for Stress Urinary Incontinence
Updated: 12/31/1969
A Prospective, Non-Randomized, Parallel Cohort, Multi-center Study of the Solyx™ Single Incision Sling System vs. the Obtryx™ II Sling System for the Treatment of Women With Stress Urinary Incontinence
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Post Market Study Of Single Incision Sling Versus Transobturator Sling for Stress Urinary Incontinence
Updated: 12/31/1969
A Prospective, Non-Randomized, Parallel Cohort, Multi-center Study of the Solyx™ Single Incision Sling System vs. the Obtryx™ II Sling System for the Treatment of Women With Stress Urinary Incontinence
Status: Enrolling
Updated: 12/31/1969
Post Market Study Of Single Incision Sling Versus Transobturator Sling for Stress Urinary Incontinence
Updated: 12/31/1969
A Prospective, Non-Randomized, Parallel Cohort, Multi-center Study of the Solyx™ Single Incision Sling System vs. the Obtryx™ II Sling System for the Treatment of Women With Stress Urinary Incontinence
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Post Market Study Of Single Incision Sling Versus Transobturator Sling for Stress Urinary Incontinence
Updated: 12/31/1969
A Prospective, Non-Randomized, Parallel Cohort, Multi-center Study of the Solyx™ Single Incision Sling System vs. the Obtryx™ II Sling System for the Treatment of Women With Stress Urinary Incontinence
Status: Enrolling
Updated: 12/31/1969
Post Market Study Of Single Incision Sling Versus Transobturator Sling for Stress Urinary Incontinence
Updated: 12/31/1969
A Prospective, Non-Randomized, Parallel Cohort, Multi-center Study of the Solyx™ Single Incision Sling System vs. the Obtryx™ II Sling System for the Treatment of Women With Stress Urinary Incontinence
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Post Market Study Of Single Incision Sling Versus Transobturator Sling for Stress Urinary Incontinence
Updated: 12/31/1969
A Prospective, Non-Randomized, Parallel Cohort, Multi-center Study of the Solyx™ Single Incision Sling System vs. the Obtryx™ II Sling System for the Treatment of Women With Stress Urinary Incontinence
Status: Enrolling
Updated: 12/31/1969
Post Market Study Of Single Incision Sling Versus Transobturator Sling for Stress Urinary Incontinence
Updated: 12/31/1969
A Prospective, Non-Randomized, Parallel Cohort, Multi-center Study of the Solyx™ Single Incision Sling System vs. the Obtryx™ II Sling System for the Treatment of Women With Stress Urinary Incontinence
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Post Market Study Of Single Incision Sling Versus Transobturator Sling for Stress Urinary Incontinence
Updated: 12/31/1969
A Prospective, Non-Randomized, Parallel Cohort, Multi-center Study of the Solyx™ Single Incision Sling System vs. the Obtryx™ II Sling System for the Treatment of Women With Stress Urinary Incontinence
Status: Enrolling
Updated: 12/31/1969
Post Market Study Of Single Incision Sling Versus Transobturator Sling for Stress Urinary Incontinence
Updated: 12/31/1969
A Prospective, Non-Randomized, Parallel Cohort, Multi-center Study of the Solyx™ Single Incision Sling System vs. the Obtryx™ II Sling System for the Treatment of Women With Stress Urinary Incontinence
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Post Market Study Of Single Incision Sling Versus Transobturator Sling for Stress Urinary Incontinence
Updated: 12/31/1969
A Prospective, Non-Randomized, Parallel Cohort, Multi-center Study of the Solyx™ Single Incision Sling System vs. the Obtryx™ II Sling System for the Treatment of Women With Stress Urinary Incontinence
Status: Enrolling
Updated: 12/31/1969
Post Market Study Of Single Incision Sling Versus Transobturator Sling for Stress Urinary Incontinence
Updated: 12/31/1969
A Prospective, Non-Randomized, Parallel Cohort, Multi-center Study of the Solyx™ Single Incision Sling System vs. the Obtryx™ II Sling System for the Treatment of Women With Stress Urinary Incontinence
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Post Market Study Of Single Incision Sling Versus Transobturator Sling for Stress Urinary Incontinence
Updated: 12/31/1969
A Prospective, Non-Randomized, Parallel Cohort, Multi-center Study of the Solyx™ Single Incision Sling System vs. the Obtryx™ II Sling System for the Treatment of Women With Stress Urinary Incontinence
Status: Enrolling
Updated: 12/31/1969
Post Market Study Of Single Incision Sling Versus Transobturator Sling for Stress Urinary Incontinence
Updated: 12/31/1969
A Prospective, Non-Randomized, Parallel Cohort, Multi-center Study of the Solyx™ Single Incision Sling System vs. the Obtryx™ II Sling System for the Treatment of Women With Stress Urinary Incontinence
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Post Market Study Of Single Incision Sling Versus Transobturator Sling for Stress Urinary Incontinence
Updated: 12/31/1969
A Prospective, Non-Randomized, Parallel Cohort, Multi-center Study of the Solyx™ Single Incision Sling System vs. the Obtryx™ II Sling System for the Treatment of Women With Stress Urinary Incontinence
Status: Enrolling
Updated: 12/31/1969
Post Market Study Of Single Incision Sling Versus Transobturator Sling for Stress Urinary Incontinence
Updated: 12/31/1969
A Prospective, Non-Randomized, Parallel Cohort, Multi-center Study of the Solyx™ Single Incision Sling System vs. the Obtryx™ II Sling System for the Treatment of Women With Stress Urinary Incontinence
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Trial Comparing Combination Treatment (Solifenacin Plus Mirabegron) With One Treatment Alone (Solifenacin)
Updated: 12/31/1969
A Randomized, Double-Blind, Multi-Centre Study to Evaluate the Efficacy and Safety of Adding Mirabegron to Solifenacin in Incontinent OAB Subjects Who Have Received Solifenacin for 4 Weeks and Warrant Additional Relief for Their OAB Symptoms
Status: Enrolling
Updated: 12/31/1969
A Trial Comparing Combination Treatment (Solifenacin Plus Mirabegron) With One Treatment Alone (Solifenacin)
Updated: 12/31/1969
A Randomized, Double-Blind, Multi-Centre Study to Evaluate the Efficacy and Safety of Adding Mirabegron to Solifenacin in Incontinent OAB Subjects Who Have Received Solifenacin for 4 Weeks and Warrant Additional Relief for Their OAB Symptoms
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Trial Comparing Combination Treatment (Solifenacin Plus Mirabegron) With One Treatment Alone (Solifenacin)
Updated: 12/31/1969
A Randomized, Double-Blind, Multi-Centre Study to Evaluate the Efficacy and Safety of Adding Mirabegron to Solifenacin in Incontinent OAB Subjects Who Have Received Solifenacin for 4 Weeks and Warrant Additional Relief for Their OAB Symptoms
Status: Enrolling
Updated: 12/31/1969
A Trial Comparing Combination Treatment (Solifenacin Plus Mirabegron) With One Treatment Alone (Solifenacin)
Updated: 12/31/1969
A Randomized, Double-Blind, Multi-Centre Study to Evaluate the Efficacy and Safety of Adding Mirabegron to Solifenacin in Incontinent OAB Subjects Who Have Received Solifenacin for 4 Weeks and Warrant Additional Relief for Their OAB Symptoms
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Trial Comparing Combination Treatment (Solifenacin Plus Mirabegron) With One Treatment Alone (Solifenacin)
Updated: 12/31/1969
A Randomized, Double-Blind, Multi-Centre Study to Evaluate the Efficacy and Safety of Adding Mirabegron to Solifenacin in Incontinent OAB Subjects Who Have Received Solifenacin for 4 Weeks and Warrant Additional Relief for Their OAB Symptoms
Status: Enrolling
Updated: 12/31/1969
A Trial Comparing Combination Treatment (Solifenacin Plus Mirabegron) With One Treatment Alone (Solifenacin)
Updated: 12/31/1969
A Randomized, Double-Blind, Multi-Centre Study to Evaluate the Efficacy and Safety of Adding Mirabegron to Solifenacin in Incontinent OAB Subjects Who Have Received Solifenacin for 4 Weeks and Warrant Additional Relief for Their OAB Symptoms
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Trial Comparing Combination Treatment (Solifenacin Plus Mirabegron) With One Treatment Alone (Solifenacin)
Updated: 12/31/1969
A Randomized, Double-Blind, Multi-Centre Study to Evaluate the Efficacy and Safety of Adding Mirabegron to Solifenacin in Incontinent OAB Subjects Who Have Received Solifenacin for 4 Weeks and Warrant Additional Relief for Their OAB Symptoms
Status: Enrolling
Updated: 12/31/1969
A Trial Comparing Combination Treatment (Solifenacin Plus Mirabegron) With One Treatment Alone (Solifenacin)
Updated: 12/31/1969
A Randomized, Double-Blind, Multi-Centre Study to Evaluate the Efficacy and Safety of Adding Mirabegron to Solifenacin in Incontinent OAB Subjects Who Have Received Solifenacin for 4 Weeks and Warrant Additional Relief for Their OAB Symptoms
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Trial Comparing Combination Treatment (Solifenacin Plus Mirabegron) With One Treatment Alone (Solifenacin)
Updated: 12/31/1969
A Randomized, Double-Blind, Multi-Centre Study to Evaluate the Efficacy and Safety of Adding Mirabegron to Solifenacin in Incontinent OAB Subjects Who Have Received Solifenacin for 4 Weeks and Warrant Additional Relief for Their OAB Symptoms
Status: Enrolling
Updated: 12/31/1969
A Trial Comparing Combination Treatment (Solifenacin Plus Mirabegron) With One Treatment Alone (Solifenacin)
Updated: 12/31/1969
A Randomized, Double-Blind, Multi-Centre Study to Evaluate the Efficacy and Safety of Adding Mirabegron to Solifenacin in Incontinent OAB Subjects Who Have Received Solifenacin for 4 Weeks and Warrant Additional Relief for Their OAB Symptoms
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Trial Comparing Combination Treatment (Solifenacin Plus Mirabegron) With One Treatment Alone (Solifenacin)
Updated: 12/31/1969
A Randomized, Double-Blind, Multi-Centre Study to Evaluate the Efficacy and Safety of Adding Mirabegron to Solifenacin in Incontinent OAB Subjects Who Have Received Solifenacin for 4 Weeks and Warrant Additional Relief for Their OAB Symptoms
Status: Enrolling
Updated: 12/31/1969
A Trial Comparing Combination Treatment (Solifenacin Plus Mirabegron) With One Treatment Alone (Solifenacin)
Updated: 12/31/1969
A Randomized, Double-Blind, Multi-Centre Study to Evaluate the Efficacy and Safety of Adding Mirabegron to Solifenacin in Incontinent OAB Subjects Who Have Received Solifenacin for 4 Weeks and Warrant Additional Relief for Their OAB Symptoms
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Trial Comparing Combination Treatment (Solifenacin Plus Mirabegron) With One Treatment Alone (Solifenacin)
Updated: 12/31/1969
A Randomized, Double-Blind, Multi-Centre Study to Evaluate the Efficacy and Safety of Adding Mirabegron to Solifenacin in Incontinent OAB Subjects Who Have Received Solifenacin for 4 Weeks and Warrant Additional Relief for Their OAB Symptoms
Status: Enrolling
Updated: 12/31/1969
A Trial Comparing Combination Treatment (Solifenacin Plus Mirabegron) With One Treatment Alone (Solifenacin)
Updated: 12/31/1969
A Randomized, Double-Blind, Multi-Centre Study to Evaluate the Efficacy and Safety of Adding Mirabegron to Solifenacin in Incontinent OAB Subjects Who Have Received Solifenacin for 4 Weeks and Warrant Additional Relief for Their OAB Symptoms
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Trial Comparing Combination Treatment (Solifenacin Plus Mirabegron) With One Treatment Alone (Solifenacin)
Updated: 12/31/1969
A Randomized, Double-Blind, Multi-Centre Study to Evaluate the Efficacy and Safety of Adding Mirabegron to Solifenacin in Incontinent OAB Subjects Who Have Received Solifenacin for 4 Weeks and Warrant Additional Relief for Their OAB Symptoms
Status: Enrolling
Updated: 12/31/1969
A Trial Comparing Combination Treatment (Solifenacin Plus Mirabegron) With One Treatment Alone (Solifenacin)
Updated: 12/31/1969
A Randomized, Double-Blind, Multi-Centre Study to Evaluate the Efficacy and Safety of Adding Mirabegron to Solifenacin in Incontinent OAB Subjects Who Have Received Solifenacin for 4 Weeks and Warrant Additional Relief for Their OAB Symptoms
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Trial Comparing Combination Treatment (Solifenacin Plus Mirabegron) With One Treatment Alone (Solifenacin)
Updated: 12/31/1969
A Randomized, Double-Blind, Multi-Centre Study to Evaluate the Efficacy and Safety of Adding Mirabegron to Solifenacin in Incontinent OAB Subjects Who Have Received Solifenacin for 4 Weeks and Warrant Additional Relief for Their OAB Symptoms
Status: Enrolling
Updated: 12/31/1969
A Trial Comparing Combination Treatment (Solifenacin Plus Mirabegron) With One Treatment Alone (Solifenacin)
Updated: 12/31/1969
A Randomized, Double-Blind, Multi-Centre Study to Evaluate the Efficacy and Safety of Adding Mirabegron to Solifenacin in Incontinent OAB Subjects Who Have Received Solifenacin for 4 Weeks and Warrant Additional Relief for Their OAB Symptoms
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Trial Comparing Combination Treatment (Solifenacin Plus Mirabegron) With One Treatment Alone (Solifenacin)
Updated: 12/31/1969
A Randomized, Double-Blind, Multi-Centre Study to Evaluate the Efficacy and Safety of Adding Mirabegron to Solifenacin in Incontinent OAB Subjects Who Have Received Solifenacin for 4 Weeks and Warrant Additional Relief for Their OAB Symptoms
Status: Enrolling
Updated: 12/31/1969
A Trial Comparing Combination Treatment (Solifenacin Plus Mirabegron) With One Treatment Alone (Solifenacin)
Updated: 12/31/1969
A Randomized, Double-Blind, Multi-Centre Study to Evaluate the Efficacy and Safety of Adding Mirabegron to Solifenacin in Incontinent OAB Subjects Who Have Received Solifenacin for 4 Weeks and Warrant Additional Relief for Their OAB Symptoms
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Trial Comparing Combination Treatment (Solifenacin Plus Mirabegron) With One Treatment Alone (Solifenacin)
Updated: 12/31/1969
A Randomized, Double-Blind, Multi-Centre Study to Evaluate the Efficacy and Safety of Adding Mirabegron to Solifenacin in Incontinent OAB Subjects Who Have Received Solifenacin for 4 Weeks and Warrant Additional Relief for Their OAB Symptoms
Status: Enrolling
Updated: 12/31/1969
A Trial Comparing Combination Treatment (Solifenacin Plus Mirabegron) With One Treatment Alone (Solifenacin)
Updated: 12/31/1969
A Randomized, Double-Blind, Multi-Centre Study to Evaluate the Efficacy and Safety of Adding Mirabegron to Solifenacin in Incontinent OAB Subjects Who Have Received Solifenacin for 4 Weeks and Warrant Additional Relief for Their OAB Symptoms
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Trial Comparing Combination Treatment (Solifenacin Plus Mirabegron) With One Treatment Alone (Solifenacin)
Updated: 12/31/1969
A Randomized, Double-Blind, Multi-Centre Study to Evaluate the Efficacy and Safety of Adding Mirabegron to Solifenacin in Incontinent OAB Subjects Who Have Received Solifenacin for 4 Weeks and Warrant Additional Relief for Their OAB Symptoms
Status: Enrolling
Updated: 12/31/1969
A Trial Comparing Combination Treatment (Solifenacin Plus Mirabegron) With One Treatment Alone (Solifenacin)
Updated: 12/31/1969
A Randomized, Double-Blind, Multi-Centre Study to Evaluate the Efficacy and Safety of Adding Mirabegron to Solifenacin in Incontinent OAB Subjects Who Have Received Solifenacin for 4 Weeks and Warrant Additional Relief for Their OAB Symptoms
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Trial Comparing Combination Treatment (Solifenacin Plus Mirabegron) With One Treatment Alone (Solifenacin)
Updated: 12/31/1969
A Randomized, Double-Blind, Multi-Centre Study to Evaluate the Efficacy and Safety of Adding Mirabegron to Solifenacin in Incontinent OAB Subjects Who Have Received Solifenacin for 4 Weeks and Warrant Additional Relief for Their OAB Symptoms
Status: Enrolling
Updated: 12/31/1969
A Trial Comparing Combination Treatment (Solifenacin Plus Mirabegron) With One Treatment Alone (Solifenacin)
Updated: 12/31/1969
A Randomized, Double-Blind, Multi-Centre Study to Evaluate the Efficacy and Safety of Adding Mirabegron to Solifenacin in Incontinent OAB Subjects Who Have Received Solifenacin for 4 Weeks and Warrant Additional Relief for Their OAB Symptoms
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Trial Comparing Combination Treatment (Solifenacin Plus Mirabegron) With One Treatment Alone (Solifenacin)
Updated: 12/31/1969
A Randomized, Double-Blind, Multi-Centre Study to Evaluate the Efficacy and Safety of Adding Mirabegron to Solifenacin in Incontinent OAB Subjects Who Have Received Solifenacin for 4 Weeks and Warrant Additional Relief for Their OAB Symptoms
Status: Enrolling
Updated: 12/31/1969
A Trial Comparing Combination Treatment (Solifenacin Plus Mirabegron) With One Treatment Alone (Solifenacin)
Updated: 12/31/1969
A Randomized, Double-Blind, Multi-Centre Study to Evaluate the Efficacy and Safety of Adding Mirabegron to Solifenacin in Incontinent OAB Subjects Who Have Received Solifenacin for 4 Weeks and Warrant Additional Relief for Their OAB Symptoms
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Trial Comparing Combination Treatment (Solifenacin Plus Mirabegron) With One Treatment Alone (Solifenacin)
Updated: 12/31/1969
A Randomized, Double-Blind, Multi-Centre Study to Evaluate the Efficacy and Safety of Adding Mirabegron to Solifenacin in Incontinent OAB Subjects Who Have Received Solifenacin for 4 Weeks and Warrant Additional Relief for Their OAB Symptoms
Status: Enrolling
Updated: 12/31/1969
A Trial Comparing Combination Treatment (Solifenacin Plus Mirabegron) With One Treatment Alone (Solifenacin)
Updated: 12/31/1969
A Randomized, Double-Blind, Multi-Centre Study to Evaluate the Efficacy and Safety of Adding Mirabegron to Solifenacin in Incontinent OAB Subjects Who Have Received Solifenacin for 4 Weeks and Warrant Additional Relief for Their OAB Symptoms
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Trial Comparing Combination Treatment (Solifenacin Plus Mirabegron) With One Treatment Alone (Solifenacin)
Updated: 12/31/1969
A Randomized, Double-Blind, Multi-Centre Study to Evaluate the Efficacy and Safety of Adding Mirabegron to Solifenacin in Incontinent OAB Subjects Who Have Received Solifenacin for 4 Weeks and Warrant Additional Relief for Their OAB Symptoms
Status: Enrolling
Updated: 12/31/1969
A Trial Comparing Combination Treatment (Solifenacin Plus Mirabegron) With One Treatment Alone (Solifenacin)
Updated: 12/31/1969
A Randomized, Double-Blind, Multi-Centre Study to Evaluate the Efficacy and Safety of Adding Mirabegron to Solifenacin in Incontinent OAB Subjects Who Have Received Solifenacin for 4 Weeks and Warrant Additional Relief for Their OAB Symptoms
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Trial Comparing Combination Treatment (Solifenacin Plus Mirabegron) With One Treatment Alone (Solifenacin)
Updated: 12/31/1969
A Randomized, Double-Blind, Multi-Centre Study to Evaluate the Efficacy and Safety of Adding Mirabegron to Solifenacin in Incontinent OAB Subjects Who Have Received Solifenacin for 4 Weeks and Warrant Additional Relief for Their OAB Symptoms
Status: Enrolling
Updated: 12/31/1969
A Trial Comparing Combination Treatment (Solifenacin Plus Mirabegron) With One Treatment Alone (Solifenacin)
Updated: 12/31/1969
A Randomized, Double-Blind, Multi-Centre Study to Evaluate the Efficacy and Safety of Adding Mirabegron to Solifenacin in Incontinent OAB Subjects Who Have Received Solifenacin for 4 Weeks and Warrant Additional Relief for Their OAB Symptoms
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Trial Comparing Combination Treatment (Solifenacin Plus Mirabegron) With One Treatment Alone (Solifenacin)
Updated: 12/31/1969
A Randomized, Double-Blind, Multi-Centre Study to Evaluate the Efficacy and Safety of Adding Mirabegron to Solifenacin in Incontinent OAB Subjects Who Have Received Solifenacin for 4 Weeks and Warrant Additional Relief for Their OAB Symptoms
Status: Enrolling
Updated: 12/31/1969
A Trial Comparing Combination Treatment (Solifenacin Plus Mirabegron) With One Treatment Alone (Solifenacin)
Updated: 12/31/1969
A Randomized, Double-Blind, Multi-Centre Study to Evaluate the Efficacy and Safety of Adding Mirabegron to Solifenacin in Incontinent OAB Subjects Who Have Received Solifenacin for 4 Weeks and Warrant Additional Relief for Their OAB Symptoms
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Trial Comparing Combination Treatment (Solifenacin Plus Mirabegron) With One Treatment Alone (Solifenacin)
Updated: 12/31/1969
A Randomized, Double-Blind, Multi-Centre Study to Evaluate the Efficacy and Safety of Adding Mirabegron to Solifenacin in Incontinent OAB Subjects Who Have Received Solifenacin for 4 Weeks and Warrant Additional Relief for Their OAB Symptoms
Status: Enrolling
Updated: 12/31/1969
A Trial Comparing Combination Treatment (Solifenacin Plus Mirabegron) With One Treatment Alone (Solifenacin)
Updated: 12/31/1969
A Randomized, Double-Blind, Multi-Centre Study to Evaluate the Efficacy and Safety of Adding Mirabegron to Solifenacin in Incontinent OAB Subjects Who Have Received Solifenacin for 4 Weeks and Warrant Additional Relief for Their OAB Symptoms
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Trial Comparing Combination Treatment (Solifenacin Plus Mirabegron) With One Treatment Alone (Solifenacin)
Updated: 12/31/1969
A Randomized, Double-Blind, Multi-Centre Study to Evaluate the Efficacy and Safety of Adding Mirabegron to Solifenacin in Incontinent OAB Subjects Who Have Received Solifenacin for 4 Weeks and Warrant Additional Relief for Their OAB Symptoms
Status: Enrolling
Updated: 12/31/1969
A Trial Comparing Combination Treatment (Solifenacin Plus Mirabegron) With One Treatment Alone (Solifenacin)
Updated: 12/31/1969
A Randomized, Double-Blind, Multi-Centre Study to Evaluate the Efficacy and Safety of Adding Mirabegron to Solifenacin in Incontinent OAB Subjects Who Have Received Solifenacin for 4 Weeks and Warrant Additional Relief for Their OAB Symptoms
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials